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Introduction {#sec1}
============

Transcription of genome-encoded information into mRNA and translation of mRNA into a functional protein are the main layers of gene expression. Due to the existential need to adjust gene expression to both intracellular requirements and extracellular stimuli, both processes are subject to regulation at multiple levels. Transcription is a highly controlled process that is extensively regulated at the levels of initiation, elongation, and termination. Recent studies in eukaryotes have linked transcription to other levels of mRNA regulation, such as alternative splicing ([@bib7]), polyadenylation ([@bib25]), localization and translation ([@bib45]), and degradation ([@bib6]). Although splicing and polyadenylation are thought to be co-transcriptional, and therefore could be directly affected by the RNAPII dynamics, the effect on translation and degradation, which have distinct spatial and temporal dynamics, is more complicated to perceive. A recently formulated model explains the imprinting role of transcription by co-transcriptional recruitment of coordinator proteins ([@bib10]), which accompany the synthesized transcript and are capable of regulating its future fate.

Translation of mRNAs is controlled mainly via initiation ([@bib32]) and elongation ([@bib28]). Although several recent studies have suggested certain levels of dependency between transcription and translation ([@bib8], [@bib11], [@bib33], [@bib45]), it is not clear whether these are limited to certain subgroups of mRNAs or represent a general link. In general, transcription and translation are still regarded as mutually independent processes, characterized by different timings, cellular locations, functional complexes, and mechanisms of action.

N6-methyladenosine (m^6^A) is considered to be one of the most abundant RNA modifications, detected in thousands of human transcripts ([@bib5], [@bib21]). Several recent studies have connected m^6^A to the regulation of splicing ([@bib43]), translation ([@bib22], [@bib38]), and degradation ([@bib37]). Overall, a growing body of evidence suggests that m^6^A plays an important role in multiple levels of mRNA regulation.

In this study, we tested a hypothesis suggesting a direct flow of information from transcription to translation. Combining an unbiased screen for examination of the effect of human promoters on mRNA translation and genome-wide analyses, we identified a positive correlation between mRNA expression and translation efficiency (TE) and found that rate of transcription positively affects TE. Moreover, we observed that transcriptional dynamics are reflected in the relative deposition of m^6^A on mRNAs that affects translation. This study establishes a general and robust link between transcription and translation of mRNAs and provides a mechanistic insight regarding the way transcription epigenetically imprints mRNA molecules.

Results {#sec2}
=======

A Reporter Vector System to Examine the Transcription-Translation Relationship {#sec2.1}
------------------------------------------------------------------------------

To examine the relationship between transcription and translation, we set out to determine the effect of different human promoters on the translation of a reporter gene (Renilla luciferase \[*Rluc*\]). For this purpose, we defined promoters as 0.5- to 2.5-Kb-long regions characterized by high H3K4Me3 and low H3K4Me1 epigenetic marks upstream of transcriptional start sites (TSSs), supported by RNA sequencing (RNA-seq) data of MCF7 cells ([@bib18]). To make our screen versatile and diverse, we cloned promoters from genes connected to stress response, autophagy, ER metabolism, and metastasis, as well as multiple transcription factors. While cloning the promoter sequences, we avoided regions extending downstream the respective TSSs, as these might result in the inclusion of additional 5′ UTRs into the reporter transcripts, potentially complicating the interpretation of results. Because each of the cloned promoters drives the expression of the same reporter gene, we affiliated every promoter with a unique 10 nt barcode (cloned in the 3′ UTR of *Rluc*) in order to follow its expression in a pool of *Rluc* mRNAs ([Figure S1](#figs1){ref-type="fig"}A). Following these guidelines, we cloned 135 human promoters ([Table S1](#mmc1){ref-type="supplementary-material"}) in order to create a library named Pro-Lib, where most of the promoters were associated with two or more different barcodes to provide higher experimental confidence. As expected, cloned promoter regions substantially induced *Rluc* expression ([Figure S1](#figs1){ref-type="fig"}B). For normalization of expression, Pro-Lib included an additional reporter gene, Firefly luciferase (*Fluc*), used as an inner control ([Figure S1](#figs1){ref-type="fig"}A). Last, we employed an Flp-*FRT* recombination system and used competent Flp-In MCF7 cells to stably integrate a single copy of a Pro-Lib vector per cell in the identical genetic locus in order to avoid any possible influence of different chromatin neighborhoods on the reporter gene expression.

After establishing the library in a stable population, we performed a polysomal profiling experiment by using sucrose gradients, a classical method to separate mRNAs according to the amount of bound ribosomes. Since we examined only the barcoded *Rluc* mRNAs, their relative segregation in the gradient indicates ribosome density and TE estimation. We named the whole procedure barcoded polysomal profiling, or BPP ([Figure 1](#fig1){ref-type="fig"}A). Relative enrichment of Pro-Lib barcodes in the various fractions of the gradient showed that most *Rluc* mRNAs are localized in the initial polysomal fractions (i.e., 9--12; [Figure 1](#fig1){ref-type="fig"}B). Control total RNA segregation showed a characteristic pattern of polysomes and EDTA sensitivity, in line with the known dependence of polysomes on the availability of Mg^2+^ ions ([Figures S1](#figs1){ref-type="fig"}C and S1D).

Next, we tested whether BPP can detect changes in TE. For this purpose, we employed *Rluc* mRNA containing 5′-terminal oligopyrimidine tracts (5′ TOP) derived from *RPL37a*. Translation of mRNAs possessing 5′ TOP is highly dependent on mTOR activity, resulting in a rapid translational arrest after mTOR inhibition, as compared to other mRNAs ([@bib35]). Indeed, inhibition of mTORC1 resulted in a global moderate shift of the *Rluc* mRNAs to fractions 9--11 (e.g., SPTBN1 promoter), whereas a 5′ TOP-containing transcript was depleted from the translated fractions of the gradient ([Figure 1](#fig1){ref-type="fig"}C). Interestingly, we also identified several additional *Rluc* transcripts exhibiting similar hypersensitivity toward the inhibition of mTORC1 ([Figure S1](#figs1){ref-type="fig"}E). Further analysis of the sequences adjacent to their TSSs ([Figure S1](#figs1){ref-type="fig"}F) identified stretches of pyrimidines that could serve as 5′ TOP signals, providing a probable explanation for their dramatic response. To further test detection capabilities of BPP, we examined the effect of splicing on TE. Indeed, we observed that spliced *Rluc* mRNA shifts to heavier polysomal fractions and yields more protein ([Figure 1](#fig1){ref-type="fig"}D), as expected from the known positive effect of splicing on translation ([@bib24]). Altogether, our control experiments demonstrate that BPP is capable of examining multiple *Rluc* mRNAs in bulk and detecting changes in TE of individual transcripts.

TATA Box Confers Higher TE {#sec2.2}
--------------------------

Inspecting the segregation of the barcoded *Rluc* mRNAs on sucrose gradients, we identified 12 promoters that caused a shift of the reporter transcript toward higher ribosomal occupancy fractions in at least two independent experiments. Intriguingly, four of these promoters contained a TATA-box element ([Figure 2](#fig2){ref-type="fig"}A) and four others had TA-rich sequences that could potentially serve as non-canonical TATA boxes ([Figure S2](#figs2){ref-type="fig"}A), indicating that this promoter element could positively influence translation. To test this possibility, we supplied several TATA-less promoters with an artificial TATA element (consisting of the TATA sequence followed by the short downstream sequence derived from human *ACTB*). In all cases, this manipulation resulted in *Rluc* transcripts occupying denser fractions of the gradient (i.e., 11--13; [Figures 2](#fig2){ref-type="fig"}B and [S2](#figs2){ref-type="fig"}B), supporting the previous observations. Taking the ASNSD1 promoter as a model, we observed a positive effect of TATA addition on TE under various conditions ([Figure S2](#figs2){ref-type="fig"}C), thus indicating a robust phenomenon.

Because artificial introduction of TATA may alter the TSS, possibly impacting translational capacity ([@bib29]), we investigated in detail the 5′ UTRs produced from the TATA-containing and TATA-less promoter pairs. By northern blotting, we observed that most of the tested promoters resulted in reporter transcripts of a similar length, with a noticeable enhancement of mRNA levels in TATA-containing promoters ([Figure 2](#fig2){ref-type="fig"}C). To establish precisely the 5′ ends of the transcripts, we performed 5′ rapid amplification of cDNA ends (RACE) analyses, which showed a very narrow peak ∼25 nt downstream of the inserted TATA element ([Figures S3](#figs3){ref-type="fig"}A and S3B). To test whether these alterations in the 5′ UTRs could explain the observed changes in translation, we in vitro synthesized *Rluc* transcripts bearing the different 5′ UTRs and examined their relative TE ([Figure S3](#figs3){ref-type="fig"}C). Given that the 5′ UTR generated after the insertion of TATA sequence did not confer higher TE, we conclude that the observed positive effect of TATA on translation is unlikely to stem from the differences in the 5′ UTRs of *Rluc* mRNAs.

So far, we have inferred TE from ribosome occupancy measurements reflected by migration within sucrose gradients. Next, we tested TE changes by measuring separately the levels of the reporter mRNA and protein in the promoter pairs. As expected, we observed significantly more mRNA produced from TATA-containing promoters (7- to 9-fold, [Figure 2](#fig2){ref-type="fig"}D), consistent with the levels measured by northern blotting ([Figure 2](#fig2){ref-type="fig"}C). In contrast, the increase in the level of protein activity was significantly higher (\>20-fold), supporting the connection between the presence of TATA in promoter and enhanced protein production. To further test the role of the TATA element in translation, we mutagenized it within the SV40 promoter. Remarkably, loss of TATA reduced the reporter mRNA expression by ∼14-fold and protein activity by ∼80-fold ([Figure 2](#fig2){ref-type="fig"}E), suggesting reduced TE. Indeed, mRNA produced by a TATA-mutated promoter was enriched in the lighter polysomal fractions ([Figure 2](#fig2){ref-type="fig"}F), further supporting this indication. We observed similar results upon mutagenesis of TATA in other promoters ([Figures S2](#figs2){ref-type="fig"}D and S2E), suggesting that this effect is not restricted to any particular promoter.

Next, we tested whether the positive effect of TATA on TE also applies to the endogenous mammalian gene expression. For this purpose, we chose *c-Myc*, a ubiquitously expressed gene with a single active TATA-positive promoter in MCF7 cells ([Figure S2](#figs2){ref-type="fig"}F) and used the CRISPR-Cas9 system to alter its TATA sequence ([Figure 2](#fig2){ref-type="fig"}G). This strategy yielded isolated cell clones with disrupted c-Myc TATA on most of their alleles ([Figure 2](#fig2){ref-type="fig"}G and [Figure S2](#figs2){ref-type="fig"}G). Examination of c-Myc expression in these clones revealed a reduction of ∼25% in *c-Myc* mRNA and ∼50% in both protein activity and expression ([Figures 2](#fig2){ref-type="fig"}H and 2I and [S2](#figs2){ref-type="fig"}I and S2J). Moreover, polysomal profiling of *c-Myc* transcripts showed reduced ribosomal occupancy upon mutation of the TATA element ([Figures 2](#fig2){ref-type="fig"}J and [S2](#figs2){ref-type="fig"}H), whereas a control transcript displayed very similar profiles in both clones ([Figure S2](#figs2){ref-type="fig"}K), indicating a c-Myc-specific effect. Thus, we conclude that the presence of the TATA element in a promoter enhances the efficiency of mRNA translation and note the validity of this observation to multiple promoters and genes.

General Association, but Not Causal Link, between mRNA Levels and TE {#sec2.3}
--------------------------------------------------------------------

In all the cases we studied, presence of TATA in a promoter stimulated both mRNA expression levels and TE. To examine whether TE positively correlates with mRNA expression levels, we clustered the Pro-Lib BPP data to separate the transcripts of our library into two relative groups, one with lower TE ([Figures S4](#figs4){ref-type="fig"}A and S4B) and another with higher TE ([Figures S4](#figs4){ref-type="fig"}C and S4D), and compared the expression levels between these two groups. Indeed, we found that transcripts with higher TE tend to be more abundant ([Figure 3](#fig3){ref-type="fig"}A). To test whether this coupling is TATA dependent, we repeated this analysis while omitting the promoters with artificially added TATA elements. Notably, this analysis yielded similar albeit less significant results ([Figure 3](#fig3){ref-type="fig"}B), thus suggesting a positive correlation between the abundance of *Rluc* transcripts and their TE, with no dependency on TATA. To further test this observation, we employed cells expressing an inducible version of the barcoded reporter gene (*TRex-Rluc*), in which the levels of *Rluc* mRNA are stimulated ∼17-fold after induction ([Figure 3](#fig3){ref-type="fig"}C). Importantly, induction of this gene yielded a significantly greater enhancement of protein activity (∼60-fold, [Figure 3](#fig3){ref-type="fig"}C), suggesting a translational boost. Indeed, subsequent BPP analysis revealed a strong increase in the ribosome occupancy of the induced reporter mRNA ([Figure 3](#fig3){ref-type="fig"}D and [Figure S5](#figs5){ref-type="fig"}A), supporting the notion that increased expression results in higher TE. Notably, we performed 5′ RACE analysis of both induced and non-induced *TRex-Rluc* mRNAs and found the scattering of TSSs to be very similar ([Figure S3](#figs3){ref-type="fig"}D). Altogether, we conclude that the observed link between the expression levels of mRNAs and their TE is not restricted to the TATA element and might therefore represent a more general phenomenon.

To test whether genome-wide data support a global relationship between mRNA level and TE, we analyzed pairs of RNA-seq and Ribo-seq (ribosomal footprinting sequencing) datasets from multiple human cell lines. Intriguingly, we observed a positive global correlation between mRNA expression level and TE, which was rather weak but consistent and statistically significant ([Figure 3](#fig3){ref-type="fig"}E). Moreover, this correlation between mRNA levels and TE was also apparent in various stress conditions ([Figures S5](#figs5){ref-type="fig"}B and S5C). These results indicate that there is a positive correlation between expression levels of mRNAs and their TE in mammalian genomes as well.

To examine whether mRNA levels could directly regulate TE, we transfected different amounts of in vitro transcribed and purified *Rluc* mRNA into MCF7 cells and monitored the activity of the produced Rluc protein. We anticipated that if levels of mRNA positively stimulated TE, transfecting increasing amounts of mRNA would result in an exponential increase of protein production. However, we observed a clear linear dependency between the two parameters ([Figure 3](#fig3){ref-type="fig"}F), suggesting indifference of the protein production rates to mRNA abundance. To test this conclusion further, we employed lentiviral-mediated stable integration of a transcriptional unit including a promoter and *Rluc* gene and generated two stable populations with either nearly single or multiple integrations of the same transcriptional unit per cell, resulting in an ∼9-fold difference in *Rluc* mRNA levels ([Figure 3](#fig3){ref-type="fig"}G). Also here, increase in protein activity was similar to the increase in mRNA levels, indicating comparable TEs. Supporting this conclusion, *Rluc* mRNAs derived from both cell populations exhibited similar segregation patterns in sucrose gradients ([Figure 3](#fig3){ref-type="fig"}H). Altogether, these results suggest that while mRNA expression levels positively correlate with TE in multiple cellular models, mRNA abundance does not directly regulate it.

Rate of Transcription Positively Affects TE {#sec2.4}
-------------------------------------------

Next we searched for the causal origin of the observed correlation between mRNA levels and TE. We considered the rate of transcription to be the most likely candidate since it directly regulates the expression levels of mRNAs. To test this possibility, we correlated transcription rates, as estimated by global run-on sequencing (GRO-seq) ([@bib4]), and TE, as determined by Ribo-seq and RNA-seq data, in BJ and MCF7 cell lines. In both cell types, we observed a significant positive association between the rates of transcription and TE of genes that do not possess upstream ORFs ([Figure 4](#fig4){ref-type="fig"}A and [Figures S6](#figs6){ref-type="fig"}A and S6B). This correlation is notable given that this analysis integrates distinct datasets independently obtained from three genomic techniques in two different cellular systems.

To further investigate the relationship between rates of transcription and TE, we employed camptothecin (CPT), a chemical compound that inhibits topoisomerase I and, in mild concentrations, slows down the progression of transcribing RNA polymerase II (RNAPII) ([@bib7]). Indeed, when CPT was applied in parallel to the induction of TRex-Rluc gene, we observed a reduction of ∼60% of *Rluc* mRNA, but a more prominent reduction of Rluc activity of ∼80% ([Figure 4](#fig4){ref-type="fig"}B). This difference could be explained by the reduced ribosome occupancy, as reflected by polysomal profiling analyses ([Figure 4](#fig4){ref-type="fig"}C and [Figure S5](#figs5){ref-type="fig"}D). Thus, impediment of RNAPII progression does not only reduce the transcriptional rate of *TRex-Rluc* but also attenuates its TE. To further test the role of RNAPII dynamics on translation, we assessed TE of multiple genes in CPT-treated cells. Overall, CPT treatment resulted in TE reduction of approximately 700 genes by more than 1.5-fold in two independent experiments ([Table S2](#mmc2){ref-type="supplementary-material"}). Given that highly transcribed genes showed higher TE ([Figure 4](#fig4){ref-type="fig"}A), we speculated that CPT treatment would cause a more pronounced repressive effect on the translation of these genes. Indeed, intersection with GRO-seq data demonstrated that impediment of RNAPII caused a significant reduction in TE of genes with a relatively high transcription rate ([Figure 4](#fig4){ref-type="fig"}D). We further examined the polysomal segregation of several mRNAs, suggested by the genome-wide experiments, and validated that these mRNAs indeed displayed reduced TE coupled with reduced expression, as compared to *ALG8* control mRNA ([Figure 4](#fig4){ref-type="fig"}E). To eliminate the possibility that the transcripts exhibiting translational shifts are truncated due to the CPT treatment, we re-examined these and other mRNAs by using primers annealing to 3′ UTRs only. Also in this case, the shift of mRNAs was apparent ([Figure S6](#figs6){ref-type="fig"}C). Taken together, we conclude that transcription rate is an important positive determinant of TE.

Transcription-Dependent Translation Regulation Requires Canonical Translation Initiation {#sec2.5}
----------------------------------------------------------------------------------------

To further examine the mechanism by which transcription affects TE, we introduced an internal ribosome entry site (IRES) sequence into the inducible TRex-Rluc cassette (*TRex-IRES-Rluc*, see schematics in [Figure 4](#fig4){ref-type="fig"}F) to bypass the canonical 5′ cap-mediated initiation of translation. Interestingly, induction of *TRex-IRES-Rluc* resulted in Rluc activity that mirrored the changes in the mRNA levels (i.e., ∼12- to 15-fold induction at both levels, [Figure 4](#fig4){ref-type="fig"}F), which contrasted the previously observed induction of the Rluc protein activity (\>60-fold, [Figure 3](#fig3){ref-type="fig"}C). Moreover, BPP analyses revealed similar segregation of both induced and non-induced *IRES-Rluc* mRNAs ([Figure 4](#fig4){ref-type="fig"}G), further suggesting lack of translational induction. Furthermore, introduction of IRES into constructs containing the artificial TATA element (e.g., SZT2 promoter) abolished the previously observed enhancement of TE ([Figure 4](#fig4){ref-type="fig"}H, compare with [Figure 2](#fig2){ref-type="fig"}D) and resembled the effect of TATA mutagenesis ([Figure S2](#figs2){ref-type="fig"}D). Thus, we conclude that canonical translation initiation is required for transcription-dependent enhancement of translation.

m^6^A Modification Mediates Transcription-Responsive Translation {#sec2.6}
----------------------------------------------------------------

Next, we looked for a molecular event that could explain the link between transcription and translation. Since changes in transcription affected translation of multiple genes ([Table S2](#mmc2){ref-type="supplementary-material"}), we reasoned that this molecular event should be robust and widespread. m^6^A is an abundant nuclear dynamic mRNA modification identified in thousands of human transcripts ([@bib5], [@bib21]), recently implicated in translational regulation ([@bib38]). Therefore, we asked whether m^6^A could bridge transcription and translation.

First, we examined whether m^6^A levels could be affected by different rates of transcription. We therefore performed immunoprecipitations of m^6^A-modified RNAs (MeRIP) from cells with either induced or non-induced *TRex-Rluc* and compared the relative recoveries of the different *Rluc* transcripts. Strikingly, we observed very significant differences between the two *Rluc* populations; the non-induced mRNA was isolated much more efficiently in all tested mRNA regions ([Figure 5](#fig5){ref-type="fig"}A). Importantly, a control mRNA (AHNAK) showed similar recovery in both samples, suggesting a specific enrichment of the non-induced *Rluc* transcripts by MeRIP. We also assessed the methylation levels of *Rluc* mRNAs of the two populations expressing different copy numbers of *Lenti-Rluc* ([Figure 3](#fig3){ref-type="fig"}G) and found them to be very similar ([Figure S6](#figs6){ref-type="fig"}D), suggesting that the differences observed in MeRIP are unlikely to stem from unequal mRNA expression levels. Furthermore, we observed differences in the post-MeRIP recovery of *Rluc* mRNAs transcribed from either TATA-containing or TATA-less promoters ([Figure S6](#figs6){ref-type="fig"}E), suggesting that promoters with intact TATA elements yield mRNAs with relatively lower m^6^A content. Next, we in vitro transcribed *Rluc* in m^6^A-compatible nuclear HeLa extract ([@bib31]), using conditions that reduce rate of transcription (e.g., elevated MgCl~2~ \[[@bib41]\] or a template with a mutated TATA box), and tested the different transcripts for m^6^A content. Indeed, both changes resulted in the relatively lower levels of *Rluc* mRNA, which were associated with higher deposition of m^6^A ([Figure 5](#fig5){ref-type="fig"}B). Importantly, both the UTRs and polyA tails of the different transcripts were similar ([Figures S3](#figs3){ref-type="fig"}E and S3F). Furthermore, treatment with CPT reduced mRNA levels in parallel to the relative enhancement of their m^6^A content ([Figure 5](#fig5){ref-type="fig"}C), suggesting a negative correlation between transcription elongation and m^6^A deposition. Additionally, we performed MeRIP analysis of genes that exhibited reduction of both mRNA levels and TE after CPT treatment ([Figure 4](#fig4){ref-type="fig"}E). These genes indeed displayed lower levels of mRNA coupled with enhanced m^6^A content ([Figure 5](#fig5){ref-type="fig"}D). To further address the link between the rate of transcription and m^6^A deposition in an additional independent system, we interrogated α-amanitin resistant RNAPII mutants exhibiting either normal (N792D) or slow (C4/R749H) rates of elongation ([@bib9]). Similarly to the previous observations, we found that cells expressing the slow RNAPII mutant contained relatively lower levels of mRNA, associated with elevated methylation content ([Figure 5](#fig5){ref-type="fig"}E). Thus, various experimental approaches indicate that a suboptimal rate of transcription results in higher m^6^A deposition on mRNAs.

This conclusion raised the possibility that m^6^A modification of mRNAs occurs co-transcriptionally, and therefore we anticipated a physical interaction between RNAPII and the methyltransferase complex (MTC). To test this, we immunoprecipitated RNAPII from either normally growing or CPT-treated cells and probed the eluate for METTL3, a catalytic core of MTC ([@bib39]). Remarkably, whereas in untreated conditions we observed no visible interaction, upon CPT treatment, METTL3 was efficiently co-precipitated ([Figure 5](#fig5){ref-type="fig"}F), suggesting co-transcriptional m^6^A modification and enhancement of the interaction between RNAPII and MTC upon impediment of RNAPII elongation dynamics.

Next, we tested whether elevated levels of m^6^A could negatively affect translation. We first examined the translation capacity of the in vitro transcribed *Rluc* mRNAs in the conditions of reduced transcription and enhanced m^6^A (as presented in [Figure 5](#fig5){ref-type="fig"}B). In line with our hypothesis, conditions associated with attenuated transcription resulted in lower efficiency of protein production compared with the normal transcription conditions ([Figure 6](#fig6){ref-type="fig"}A). Next, we examined the global effects of CPT treatment and expression of the slow RNAPII mutant on polysomes. [Figures 6](#fig6){ref-type="fig"}B and 6C show that these two treatments considerably reduced the RNA content of the polysomal fractions, suggesting a general reduction of translation and providing further evidence for the positive feedback between transcription and translation.

To directly examine the role of m^6^A in translation, we knocked down two genes in the m^6^A pathway (*METTL14* and *YTHDH1*, [Figure S6](#figs6){ref-type="fig"}F) and examined the effect on the expression of *Rluc* mRNA. Interestingly, knocking down either factor resulted in a significant boost in the expression of the non-induced Rluc, whereas the effect on the induced gene was moderate ([Figure 6](#fig6){ref-type="fig"}D). Importantly, while global polysome segregation analysis indicated only a slight effect of each knockdown on general translation ([Figure S6](#figs6){ref-type="fig"}G), possibly due to compensatory mechanisms, BPP assay verified a considerable increase in the TE of the non-induced *Rluc* mRNA in these conditions ([Figure 6](#fig6){ref-type="fig"}E). Given that methylation of coding regions (CDRs) has been recently suggested to attenuate translation ([@bib3]), we re-examined the experiment presented in [Figure 5](#fig5){ref-type="fig"}A, in order to compare the relative changes in methylation of the different *Rluc* transcript regions. Remarkably, the highest gain of methylation upon transcriptional attenuation was observed throughout the CDR of *Rluc* (up to ∼11% near the end of the non-induced mRNA CDS), whereas both UTRs (i.e., 5′ and 3′) displayed the lowest levels (\<1%, [Figure 6](#fig6){ref-type="fig"}F). This result therefore suggests a plausible explanation for the strong inhibitory effect of transcriptional repression on TE that we observed ([Figure 3](#fig3){ref-type="fig"}D). Lastly, we sought to directly examine the effect of m^6^A levels on protein production and produced *Rluc* mRNAs in vitro with different proportions of methylated adenosines. Strikingly, increased incorporation of m^6^A led to a progressive attenuation of the TE of *Rluc* ([Figure 6](#fig6){ref-type="fig"}H), suggesting an overall inhibitory effect of m^6^A modification on translation. Altogether, these results demonstrate that covalent m^6^A modification of mRNAs depends on the dynamics of the transcribing RNAPII, and tends to negatively affect TE. Therefore, we conclude that m^6^A links transcription and translation.

Discussion {#sec3}
==========

In this study, we describe a direct and general flow of information from transcription to translation in human cells. We show that genes possessing strong transcriptional activity give rise to mRNAs with greater capacity to produce proteins. We propose that this link is mediated, at least in part, by the co-transcriptional N6-methylation of adenosines in mRNA---the m^6^A modification. Suboptimal transcription results in a relatively higher m^6^A content of transcripts and this, in turn, tends to reduce TE ([Figure 6](#fig6){ref-type="fig"}H).

Initially, we employed Pro-Lib, a library consisting of multiple human promoters that drive the transcription of a single reporter gene *Rluc*, and combined it with barcoded polysomal profiling procedure to examine TE of the reporter mRNAs. This approach allowed for several advantages. First, recombination-mediated single-copy genomic integration resulted in a balanced expression of the reporter constructs. Second, all vectors were integrated into the same genetic locus, minimizing the probability of an artificial effect of chromatin neighborhood on transcription. Third, establishing a pooled stable reporter population simplified the maintenance and treatments and increased experimental accuracy. Lastly, deep sequencing of the barcodes enabled a quantitative coverage of nearly all reporter transcripts in the polysomal fractions within a single experiment.

Using Pro-Lib, we observed that promoters possessing either confirmed or suspected TATA-box element (TATA) yield transcripts characterized by a higher capacity to accommodate ribosomes and produce proteins. This indicated that the presence of this element in a promoter not only boosts transcription, but also enhances mRNA translation, suggesting a positive effect of TATA-box promoter element on TE. Indeed, a recent genome-wide bioinformatics analysis has suggested that mammalian genes possessing TATA in their promoter tend to be translated more efficiently ([@bib33]), which was attributed to their characteristics (e.g., gene length, probability of upstream ORF, etc.). In this study, we support these observations and conclude, in addition, that a mere presence of intact TATA element in a promoter potentiates mRNA translation ([Figure 2](#fig2){ref-type="fig"}B).

The TATA element activates transcription ([@bib42]), resulting in elevated levels of mRNA. Indeed, we have identified a strong correlation between mRNA levels and translation in the Pro-Lib screen; additionally, we have also shown that this link is not unique to TATA, but also holds true for the global mammalian gene expression. We note that the genome-wide correlations between mRNA levels and TE are rather weak, probably reflecting multiple additional levels of regulation, but statistically significant. Interestingly, similar correlations were noticed in both animal cells and yeast ([@bib30], [@bib40]), likely indicating an evolutionarily conserved phenomenon. Importantly, while mRNA levels could be linked to TE via mechanisms that couple mRNA stability and translation ([@bib27]), we found that mRNA levels per se do not directly affect translation ([Figures 3](#fig3){ref-type="fig"}F--3H). Instead, we observed a global positive effect of transcription on TE. Impediment of transcription, either via CPT treatment or in the in vitro assays, demonstrated a role for transcriptional elongation in the determination of TE. Given that transcription initiation and elongation are related processes ([@bib20]), future studies are necessary in order to precisely appreciate the role of transcription initiation in the regulation of translation. Regarding mRNA translation, our observations suggest that it is responsive to transcriptional changes only when the initiation of translation involves 5′ cap. When this canonical initiation was bypassed by the introduction of an IRES, the translation machinery failed to respond to transcriptional fluctuations ([Figures 4](#fig4){ref-type="fig"}F--4H), indicating that this initial step, which is considered to be rate limiting and highly controlled, might exert additional aspects of translational regulation.

Here, we suggest that m^6^A, at least partially, mediates the communication between transcription and translation. Our results indicate that attenuated transcription leads to enhanced methylation of mRNAs. We present here biochemical evidence for a physical interaction between the METTL3 enzymatic subunit of the MTC and retarded RNAPII ([Figure 5](#fig5){ref-type="fig"}F). These results suggest that m^6^A modification is, at least in part, co-transcriptional and indicate that the affinity between MTC and RNAPII depends upon the dynamics of the latter. Although it remains unclear how exactly this interaction is induced, we propose that slow progression or frequent pausing of RNAPII increases the probability of MTC engagement. The global enrichment of modified nucleotides at the start of mRNAs and around STOP codons ([@bib21], [@bib5]) supports this hypothesis, as these are the locations of probable RNAPII pausing ([@bib14]). Since a considerable proportion of genes experience slow or paused transcription ([@bib4]), it would be important to examine, in future studies, whether these genes are preferentially methylated. We note that, together with m^6^A, additional factors might bridge transcription and translation, such as precise sequence of 5' UTR ([@bib29], [@bib34]) and recruitment of mRNA coordinators ([@bib11]).

Globally, we observed that enhanced mRNA methylation results in lower translation capacity. Interestingly, several recent studies have indeed linked m^6^A to translation, but report mainly a stimulatory role of this modification ([@bib22], [@bib38], [@bib44]). We anticipate that the precise effect of m^6^A on translation depends on the location of the modified nucleotide within the transcript. Remarkably, most of the mentioned studies observed enhanced methylation within UTRs of transcripts. In contrast, methylation within CDRs reduced translation ([@bib26]), probably due to the attenuated elongation ([@bib12], [@bib3]). Given that most of the methylated residues are located within CDRs, we would anticipate an overall negative effect of m^6^A methylation on translation, which we indeed observed upon random incorporation of modified adenosines ([Figure 6](#fig6){ref-type="fig"}G).

Our study suggests that m^6^A modification of mRNAs is co-transcriptional and is used to epigenetically imprint mRNAs and control their future activity and fate. This way the dynamics of the transcription process could be recorded in the methylation profile of a given mRNA, which, in turn, could further impact multiple steps of mRNA biology.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------
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Contact for Reagent and Resource Sharing {#sec4.2}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Reuven Agami (<r.agami@nki.nl>).

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

Human breast adenocarcinoma MCF7 cells (female) were purchased from ATCC and authenticated by detecting the deficiency of caspase-3 using western blotting. These cells were grown in DMEM media (GIBCO) supplemented with 10% bovine serum and penicillin/streptomycin (GIBCO) in 5%CO~2~-buffered incubators at 37°C. Cells were split twice per week and kept in culture for up to 8 weeks. To create cells compatible with FLP recombination system (ThermoFisher scientific), MCF7 cells were transfected with the pFRT/*lac*Zeo and grown in the presence of Zeocin (400μg/ml) until stable colonies appeared. These cells were named MCF7/FRT and used for integration of Pro-Lib. To integrate Pro-Lib, these cells were transfected with Pro-Lib vectors along with pOG44 vector (ThermoFisher scientific) in quantities of 1.6μg+3μg respectively, per 35-mm well. After 48h, the cells were collected, re-plated onto 10-cm dishes, and selected for three weeks in the presence of Hygromycin (0.1 mg/ml f.c.). After appearance of the stable colonies, the cells were collected, frozen, and used for further experiments. To create cells compatible with T-REx inducible system (Invitrogen), MCF7/FRT cells were transfected with pcDNA6/TR vector encoding for the tetracycline-sensitive repressor and separate clones were selected for their resistance to Blasticidin S (5mg/ml). The induction efficiency was examined in separate clones by transient transfection with pcDNA4/TO-Rluc construct, incubation with Doxycycline (Sigma, 1 μg/ml final conc.) for 17 hr and measurement of Renilla protein activity. One suitable clone was chosen for further experiments and the cells were named MCF7/FRT/TR. These cells were stably transfected with pcDNA5/FRT/TO plasmid encoding for barcoded Renilla ORF (TRex-Rluc) in the presence of pOG44 vector (ThermoFisher scientific) and grown for three weeks in the presence of Hygromycin (0.1 mg/ml f.c.). Individual colonies were isolated and tested by treatment with Doxycycline (Sigma, 1 μg/ml final conc.). 293 cells bearing integrated alpha-amanitin resistant mutants of Rpb1("wild-type" N792D, and "slow" C4/R749H), were a kind gift of D. Bentley. They were maintained in DMEM supplemented with 10% FBS, 1% penicillin/streptomycin, 200 μg/mL hygromycin, and 6.5 μg/mL blasticidin. To stimulate the expression of Rpb1 mutants, cells were induced with 2.0 μg/mL doxycycline for 16 hr and treated with 2.5 μg/mL α-amanitin for additional 42 hr.

Method Details {#sec4.4}
--------------

### Manipulations in Cells {#sec4.4.1}

To induce autophagy, MCF7 cells were incubated in EBSS (GIBCO) medium for 3 hr. To inhibit mTORC1, Torin1 was added to the medium for 2 hr (250 nM; Tocris Bioscience, Bristol, UK). Cells were irradiated at 10Gy dose and then incubated for additional 18 hr at normal conditions. To arrest cells in mitosis, Taxol (Sigma-Aldrich, 1 μM f.c. for 17 hr) was added to the growth medium. FuGENE6 (Roche) was used for transfection of DNA plasmids, DharmaFECT1 (Dharmacone) for transfection of siRNAs and in-vitro transcribed mRNAs, according to the manufacturers' instructions. To impede the dynamics of transcribing RNA polII, cells were treated with Camptothecin (CPT, Sigma) to the final conc. of 6 μM for the indicated times.

### DNA Cloning {#sec4.4.2}

Psi-Check2 vector with cloned FRT sequence and hygromycin-resistance gene served as the basic vector for the construction of Pro-Lib. To clone human promoters upstream of the Renilla ORF in Pro-Lib, putative promoter regions were cloned between BglII and NheI sites of the basic Pro-Lib vector ([Figure S1](#figs1){ref-type="fig"}A) after addition of random barcodes and removal of the SV40 promoter. All barcodes were sequenced as well as the proximal parts of the cloned promoter regions to confirm their identity. All other cloning procedures were performed using standard procedures; DNA was extracted from gel using Agarose Gel DNA Extraction Kit (Roche); all constructs were sequenced. The list of the plasmids used in the study together with their details is available in [Table S3](#mmc3){ref-type="supplementary-material"}.

### Luciferase Assay {#sec4.4.3}

Luciferase assay was measured using Dual-Luciferase Reporter assay kit (Promega). Cultured cells were lysed with passive lysis buffer for 15 min at room temperature. Renilla (Rluc) and Firefly (Fluc) enzymatic activities were assayed with the substrates supplied with the kit using Centro XS^3^ LB960 machine (Berthold technologies). Typically, expression of Fluc was used to normalize the Rluc expression. Myc activity was measured using Myc-reporter constructs (pGL3-M4 and pGL3-M4-mut, ([@bib23]). MCF7 cells (1x10^5^ cells) were plated in 12-well plates and transfected with 200ng of the reporter constructs using Fugene-6 (Promega). Luciferase activity was measured 36 hr after transfection.

### Barcoded Polysomal Profiling {#sec4.4.4}

Sucrose gradients for separation of polysomes were usually prepared by gentle sequential addition of 2.2ml of the different sucrose solutions (e.i., 47, 37, 27, 17 and 7% in Tris-HCl pH = 7.5 (f.c. 20mM), MgCl~2~ (f.c. 10mM) and KCl (f.c. 100mM), supplemented with 2mM DTT, Ribosafe RNase inhibitor (Bioline, 1 μl/ml) and CHX (100 μg/ml) into a 12 mL tube (Beckman, 9/16 × 3 1/2 in.) and left overnight at 4°C to achieve continuous gradient prior to the centrifugation. Cells growing in subconfluent conditions (typically ≈80%--85% confluency) were washed once with ice-cold PBS, collected into 15 mL tubes and incubated with PBS/cycloheximide (CHX, 100 μg/ml) for 5 min on ice. After sedimentation (400xg for 3min), the cells were lysed in lysis buffer (20 mM Tris-HCl (pH 7.5), 10 mM MgCl~2~, 100 mM KCl, 1% NP40) supplemented with EDTA-free cOmplete Protease Inhibitors (Roche), 2mM DTT, Ribosafe RNase inhibitor (Bioline, 1 μl/ml) and CHX (100 μg/ml) for 10min on ice. To resolve cell aggregations, the lysates were passed three times through a 25G needle. The lysates were centrifuged 1300xg for 10 min at 4°C and the supernatants were transferred into new tubes. From the cleared lysates, 500 μL were loaded on top of each gradient, mounted on SW41TI rotor and centrifuged at 36000rpm for 2 hr at 4°C. Following the centrifugation, each gradient was split into 15 equal fractions of 760 μl, which were subjected to RNA isolation using TRIsure (Bioline) according to the manufacturer's instructions. RNA was precipitated from 750 μL of the collected material, using 2 μL of GlycoBlue (Ambion) and 750 μL of isopropanol, washed once with 70% of ethanol and reconstituted in 25 μL of water. Typically, 7 μL of total RNA were taken as a template for reverse transcription reactions using Tetro cDNA synthesis kit (Bioline) and oligo dT primers. Barcodes of the Pro-Lib transcripts detected by qRT-PCR using specific primers. To construct libraries ready for deep sequencing, barcodes were PCR amplificed using indexed primers bearing P5, P7 and Illuseq sequences, while each collected fraction was associated with a unique index. The PCR products were cleaned using QIAquick PCR purification kit (QIAGEN), size selected on E-Gel SizeSelect 2% gels (Invitrogen) and sequenced using Illumina Hi-seq 2000 or 2500.

### RNA Manipulations {#sec4.4.5}

RNA was isolated from cultured cells using TRI-sure reagent (Bioline) according to the manual, using Glycoblue (Ambion) as a carrier. RNA was typically reconstituted in 30 μL of sterile nuclease-free water (GIBCO) and stored at −20°C. To analyze RNA on agarose gels, a portion of isolated RNA was mixed with equal volume of 2xRNA-loading dye (Thermo Fisher Scientific), supplemented with 20ng/ml Ethidium bromide, heated at 70°C for 5min and loaded on 1.5% agarose gel. After separation at 100mV for 30min, gels were visualized and documented. Reverse transcription was done using Tetro cDNA synthesis kit (Bioline) according to the manual. Typically, 7 μL of total RNA was taken for a single RT reaction. Real-time PCR experiments were performed using SensiFAST CYBR (Bioline) reagent and LightCycler 480II (Roche) using standard conditions.

### In Vitro Synthesis of mRNA {#sec4.4.6}

To synthesize *Renilla* mRNA using nuclear extract, we used HeLaScribe Nuclear Extract in vitro Transcription System (Promega) according to the manufacturer's protocol. Briefly, DNA templates including promoter, ORF, UTRs and polyA site were PCR-amplified from the appropriate pGEM-T vectors, isolated on agarose gels and cleaned. For a single reaction, 200ng of a clean template were transcribed with 7 μL of nuclear extract, in a buffer containing 1.5mM MgCl~2~ in a siliconized RNase-free 1.5 mL eppendorf tube (Ambion) at 30°C for 1.5 hr. The reaction was stopped by addition of TRIsure compound (Bioline) and RNA was isolated, analyzed on agarose gels, quantified using NanoDrop, compared using ImageJ and stored at −20°C. Transfection was done in 96-wells plates using Dharmafect1 agent (Thermo Scientific), according to the manufacturer's instructions. Approximately 10ng of recovered mRNA were transfected as x1-amount. Rluc activity was measured ≈24 hr following transfection. For m^6^A measurements, reconstituted synthetic RNA was furthermore cleaned using RNeasy kit (QIAGEN). To synthesize *Renilla* mRNA using T7 RNA polymerase, we used HiScribe T7 High Yield RNA Synthesis kit (NEB) according to the manufacturer's instruction. Briefly, PCR-produced DNA fragments encoding for *Renilla* ORF were transcribed in presence of Ribo m7G Cap Analog (Promega, 8mM f.c.) at 37°C for 2 hr followed by DNase treatment for 15 min and isolation of RNA. To produce transcripts with methylated content, N6-Methyladenosine-5′-Triphosphate (Trilink, 100mM stock conc.) was added together with ATP (supplied in the kit) at the indicated proportions. After recovery, the RNAs were polyadenylated using *E.Coli* Poly(A) polymerase (NEB) and purified. After recovery and analysis on gels, RNAs were transfected into living cells as described above or subjected to *in-vitro* translation.

### In vitro translation of mRNAs {#sec4.4.7}

To translate mRNAs encoding for Rluc protein, rabbit reticulocytes system, nuclease treated (Promega) was employed, according to the manufacturer's protocol. All reactions were done in volume of 25 μL at 30°C for 10 min. To quantify the produced Rluc protein, aliquots of 5 μL were taken for luciferase measurements using Dual-Luciferase Reporter assay kit (Promega).

### Northern Blotting {#sec4.4.8}

Total RNA was extracted from growing MCF7 cells as described and enriched for mRNA using Oligotex kit (QIAGEN). Equal volumes of reconstituted RNA were separated on 1.2% agarose gel supplemented with 0.66% (vol/vol) formaldehyde and transferred onto Amersham Hybond-N^+^ membrane (GE Healthcare). RNA probes targeting *Renilla* or *Firefly* mRNAs were produced by in vitro transcription (T7 high yield kit, NEB) of PCR fragments encoding for sequences complementary to these transcripts (see [Table S4](#mmc3){ref-type="supplementary-material"} for used oligos) using ^32^P(α)-UTP. Following cleaning of the probes using MicroSpin G-50 columns (GE Healthcare), hybridization was performed in ULTRAhyb Hybridization buffer (Ambion) rotating at 68°C for 4 hr. The membrane was washed twice with 2xSSC buffer supplemented with 0.1%SDS and twice with 0.2xSSC buffer supplemented with 0.1%SDS. The signal was detected by FujiFilm FLA-3000 PhosphorImager and analyzed using ImageJ.

### Measurement of m6A Content {#sec4.4.9}

To estimate the relative m^6^A content of RNA, EpiQuik m6A RNA Methylation Quantification Kit (Epigentek) was used. Briefly, equal volumes of RNA solution (4-8 μl) were processed according to the manufacturer's instructions, aside with the negative, positive, and standards controls.

### 5′ RACE Analysis {#sec4.4.10}

Generally, 5′RACE experiments followed the procedure established for 5′ RACE System for Rapid Amplification of cDNA Ends, v2.0 (Invitrogen). Briefly, total RNA was extracted with TRIsure (Bioline) and subsequently poly-A selected with Oligotex Direct mRNA mini kit (QIAGEN). For each 5′ RACE assay, 500ng of poly-A selected mRNA were used for cDNA synthesis with the following primer: CCCTTCTCCTTGAATG. Synthesized cDNA were purified with QIAquick PCR purification kit (QIAGEN). Then the cDNA were dC-tailed with TdT for 10min at 37°C and a first round PCR was performed with a gene specific primer (GSP2), AGTTTCCGCATGATCTTGCTTG, and Abridged Anchor Primer (AAP). A nested PCR was performed with a nested gene specific primer (GSP1), GTTGATGAAGGAGTCCAGCACGTT, and Abridged Universal Amplification primer (AUAP). For determination of the sequences of 5′ RACE PCR products, the nested PCR products were ligated into pGEM-T vector (Promega) and transfected into competent bacteria. Unless otherwise indicated, at least 20 different bacterial colonies from each ligation were subsequently analyzed using Sanger sequencing.

### 3′ RACE Analysis {#sec4.4.11}

The protocol was adapted from 3′RACE system for rapid amplification of cDNA ends (Invitrogen). Briefly, total RNA was poly-A selected and reverse transcribed with oligo(dT)-containing adaptor primer (AP) GGCCACGCGTCGACTAGTACTTTTTTTTTTTTTTTTT. Synthesized cDNA was treated with Rnase H to remove residual RNA templates and PCR-amplified with Rluc specific primer CTGAGAGTGTCGTGGACGTGA and Abridged Anchor Primer (AAP). A nested PCR was performed with a nested Rluc primer GCCTAAGATGTTCATCGAGTCC and AAP.

### Sequencing Library Preparation of 5′ and 3′ RACE {#sec4.4.12}

PCR products from 5′ and 3′ RACE preparations were PCR-amplified with Illumina sequencing compatible primers (p5 primer, 5′RACE-p7 primer, and 3′RACE-p7 primer). PCR products were then purified with CleanPCR magnetic beads (CleanNA), and pooled with equal molar, ran on Illumina Miseq platform.

### Poly(A) Tail Analysis {#sec4.4.13}

Determination of poly(A) tail-length was performed with USB® Poly(A) tail-length assay kit (Affymetrix) following the manufactor's protocol. In short, in-vitro transcribed RNA was G/I tailed, and reverse-transcribed with specific adaptor primer (sequence not provided). The poly G/I tailed cDNA was then amplified with a Rluc specific primer (GCGTGCTGAAGAACGAGCAGTAA) and a provided universal PCR reverse primer. Finally, PCR products were resolved on a 2.5% agarose gel with ethidium bromide.

### Lentiviral Infection {#sec4.4.14}

To generate viruses with the Renilla-expressing plasmid, HEK293T cells were plated 24h prior transfection. For virus production, 3.5 μg of pVSV-G, 5 μg of pMDL-RRE and 2.5 μg of pRSV-REV was transfected with 10 μg of the expression plasmid pLenti-puro-Rluc. Lentivirus-containing supernatant was harvested 48h after the transfection, filtered through a 0.45 μm membrane (Milipore Steriflip HV/PVDF) and kept at −80°C. Subsequently, to infect MCF7 cells, 1x10^6^ cells were plated in 10-cm dish one day prior infection. For low MOI infection, cells were infected with 20 μL of the virus-containing supernatant; for high MOI infection, cells were infected with 900 μL (45-fold) of the supernatant. Cells were refreshed with DMEM 18h after infection and subsequently recovered for 24h. Afterward, low MOI-infected MCF7 cells were selected with 1 mg/mL puromycin and high MOI-infected MCF7 cells were selected with higher concentrations of puromycin (up to 25ug/mL) for 1 week.

### CRISPR/Cas9-Mediated Mutagenesis {#sec4.4.15}

For the mutagenesis of *c-Myc* TATA box sequence, lentivirus containing sgRNAs targeting the TATA box sequence were generated and subsequently used for infecting MCF7 cells as described above. After puromycin (2 μg/ml) selection, cells were plated in a 96-well plate following serial dilutions in order to achieve single cell clones of the Cas9-generated mutants. Several single cell clones were collected, expanded, and sequenced. To sequence the indel mutations within the c-Myc locus, genomic DNA was extracted from the grown colonies using DNeasy Blood and Tissue Kit (QIAGEN), PCR amplified using c-Myc promoter-specific primers, sub-cloned into pGEM-T vector (Promega) and sequenced.

### Western Blotting {#sec4.4.16}

MCF7 cells were washed with ice-cold PBS and scraped off the plate. Cells were centrifuged at 1000xg for 10min at 4°C. Subsequently, cell pellets were lysed, by adding an appropriate amount of ice-cold lysis buffer (20mM Tris-HCl at pH 7.5, 150mM NaCl, 1.8mM MgCl~2~ and 0.5% NP40) supplemented with cOmplete protease inhibitor cocktail (Roche) and 1mM DTT. Cell lysates were incubated on ice for 20min with occasional vortexing followed by centrifugation at 15000xg for 15min at 4°C. Protein concentrations were determined using Pierce BCA protein assay kit (Thermo Scientific). Proteins were separated on SDS-PAGE gels and transferred onto Nitrocellulose membrane (Bio-rad, 0.2 μM), which was blocked in 5% Blotting-grade blocker and probed with the indicated antibodies. All antibodies were diluted in PBS-0.25% Tween solution. For detection, blots were reacted with the SuperSigna West Dura Extended Duration Substrate (ThermoFisher). Images were captured with Chemidoc XRS+ (Biorad) and analyzed with Image Lab software; quantifications were done using ImageJ.

### m^6^A RNA Immunoprecipitation (MeRIP) {#sec4.4.17}

Immunoprecipitation of m6A was adapted from the protocol of EpiMark® N6-Methyladenosine Enrichment Kit (New England Biolabs). Total RNA was isolated as mentioned above and enriched for mRNA using Oligotex mRNA kit (QIAGEN) following manufacturer's instruction. The isolated mRNA was fragmented with RNA fragmentation reagent (Ambion) for 5min, 94°C and purified through ethanol precipitation. To bind antibody to the beads, protein G beads (Invitrogen) were pre-incubated with 1 μL of anti-m^6^Aantibody (Neb, Cat. E1610S) in IPP buffer (150 mM NaCl, 10 mM Tris-HCl, pH 7.5, 0.1% NP-40) at 4°C. Subsequently, the beads were washed twice in IPP buffer and incubated with RNA for 3h with head-to-tail rotation at 4°C (10% of the material were kept as input control). Afterward, beads were washed twice in IPP buffer, twice in low salt buffer (50 mM NaCl, 10 mM Tris-HCl, pH 7.5, 0.1% NP-40), and twice in high salt buffer (500 mM NaCl, 10 mM Tris-HCl, pH 7.5, 0.1% NP-40). RNA was eluted with 30 μL buffer RLT (QIAGEN, Cat. 79216) for 5min and subsquently purified through ethanol precipitation. For quantification of precipitation, both input samples and IP eluates were examined by qRT-PCR as described above.

### RNAPII Immunoprecipitation {#sec4.4.18}

MCF7 cells growing on 15-cm dishes were treated with CPT (Sigma, 6 μM f.c.) or DMSO (as a control) for 5 hr. After collection on ice, the cells were incubated in 8ml of PBS supplemented with 1% formaldehyde for 10 min at room temperature in constant rotation. After quenching with glycine (0.125M f.c.) for 5 min, the cells were spun, washed once with PBS, flash-frozen in liquid nitrogen and kept at −80°C. After thawing in 1ml of lysis buffer (50 mM HEPES-NaOH-pH7.5, 150 mM NaCl, 5 mM MgCl~2~, 0.1% NP40) supplemented with EDTA-free cOmplete Protease Inhibitors and PhosSTOP (Roche), the lysate was divided into three equal 2 mL eppendorf tubes and sonicated at 4°C using Bioraptor (Diagenode) for 10 cycles (each cycle including 30sec of high-power sonication followed by 30sec pause). The lysates were centrifuged for 10 min. at 1800xg at 4°C to remove unbroken cells. Equal volumes of supernatants were added to 20 μl of Dynabeads-Protein G suspension (Life Technologies) pre-coupled with 5 μg of anti-RNA polymerase II antibodies (Millipore, clone CTD4H8) or normal mouse IgG (Santa Cruz) in PBS and 1% BSA for 2 hr at room temperature. The IP reaction was carried out for 2 hr at 4°C with constant rotating. After that, the beads were washed once with the regular lysis buffer and three times with stringent lysis buffer (as detailed above, but with 300 mM NaCl). The last washing was done with PBS, and the beads were transferred into new 1.5 mL tubes and the bound proteins were eluted and reverse-crosslinked by incubation with 50 μL of 1x Laemmli sample buffer at 100°C for 10min. After collection, the eluates were resolved on 8% SDS-PAGE and probed with the indicated antibodies.

### Ribosomal Profiling {#sec4.4.19}

Ribosome profiling (RP) was performed as previously described ([@bib19]). Briefly, CHX (100 μg/ml) was added to the medium of growing cells and incubated for 5min at 37°C. Approximately 30x10^6^ cells were collected in ice-cold PBS and lysed in lysis buffer (20 mM Tris-HCl pH 7.8, 10 mM MgCl~2~, 100 mM KCl, 1% Triton X-100, 2 mM DTT, 100 μg/ml CHX, cOmplete protease inhibitors (Roche). Lysates were passed through a 26G needle (BD bioscience) for further homogenization, and centrifuged at 4°C 1300xg for 10 min. Supernatants were treated with 2.5U/μl of RNase I (Ambion) for 45 min at room temperature in gentle constant rotation. Lysates were loaded onto a linear sucrose gradient (7%--47%, as detailed above), and fractionated by ultracentrifugation, using a SW-41Ti rotor at 36000 rpm (221632.5g) during 2 hr. The sucrose gradient was divided into 14 fractions of 830 μl. The monosome-enriched sucrose fractions (7 to 10) were collected and treated with proteinase K (PCR grade, Roche), in presence of 1% SDS. The so-released ribosome protected fragments (RPFs) were purified using TRIsure reagent (Bioline), following the manufacturer's instructions. RPFs between 30 and 33 nucleotides in length were size-selected in 10% acrylamide gel and isolated. The 3′ ends of the RPFs were dephosphorylated by treatment with T4 polynucleotide kinase (New England Biolabs) for 6 hr at 37°C in MES-NaOH buffer (100mM MES-NaOH, pH 5.5, 10mM MgCl~2~, 10mM β-mercaptoethanol, 300mM NaCl). 3′ adaptor (RA3) was ligated using T4 RNA ligase 1 (New England Biolabs) for 3.5 hr at 37°C, in absence of ATP. Ligation products were size selected in 10% acrylamide gel, and the 5′ ends were phosphorylated by treatment with T4 polynucleotide kinase for 30 min at 37°C, in presence of 1mM ATP. 5′ adaptor (RA5) was ligated using T4 RNA ligase 1 (New England Biolabs) during 2.5h at 37°C, and the ligation products were selected in 10% acrylamide gel. Ribosomal RNA depletion was performed by biotin-streptavidin affinity purification using biotinylated ribosomal RNA probes and streptavidin dynabeads. Retro-transcription of the ligation products into cDNA was performed using Super Script III reverse-transcriptase (Invitrogen) following the manufacturer's instructions, and the primer RTP. PCR amplification was performed using the forward primer RP1, and the reverse primer RPI that contained a hexanucleotide index used to multiplex different samples during next generation sequencing (NGS). PCR products were size selected by E-Gel electrophoresis (Invitrogen), and submitted to NGS using HiSeq 2500 System (Illumina). The sequence of 3′ and 5′ adapters, RTP, RP1 and different RPI primers is available in Table S5.

### RNA-Seq {#sec4.4.20}

#### Total RNA Isolation {#sec4.4.20.1}

Total RNA was extracted using TRIzol reagent (15596-018, Ambion life technologies) according to the manufactures protocol. Briefly, 0.2x volumes of chloroform (Chloroform stab./Amylene, Biosolve) was added to the Trizol homogenate and the tube(s) (Falcon, 15mL) were shaken vigorously. The tube(s) were incubated for 2-3 min at room temperature and centrifuged (Hettich, rotanta 46 RS) for 1 hr at 4°C. Approximately 70% of the upper aqueous phase was transferred to a clean 15 mL tube and 0.5x volume of isopropanol (33539, Sigma-Aldrich,) was added. The tube(s) were incubated overnight at −20°C and centrifuged for 30 min at 4°C. The supernatant was removed and the pellet was washed twice with 80% ethanol (32221-2.5L, Sigma-Aldrich). The total RNA pellet was air-dried for 8 min and dissolved in an appropriate volume of nuclease free water (Ambion) and quantified using Nanodrop UV-VIS Spectrophotometer. The total RNA was further purified using the MinElute Cleanup Kit (74204, QIAGEN) according to the manufactures instructions. Quality and quantity of the total RNA was assessed by the 2100 Bioanalyzer using a Nano chip (Agilent, Santa Clara, CA). Total RNA samples having RIN \> 8 were subjected to library generation.

#### TruSeq Stranded mRNA Sample Preparation {#sec4.4.20.2}

Strand-specific libraries were generated using the TruSeq Stranded mRNA sample preparation kit (Illumina, RS-122-2101/2) according to the manufacturer's instructions (Illumina, Part \# 15031047 Rev. E). Briefly, polyadenylated RNA from 1000ng intact total RNA was purified using oligo-dT beads. Following purification the RNA was fragmented, random primed and reverse transcribed using SuperScript II Reverse Transcriptase (Invitrogen) with the addition of Actinomycin D. Second strand synthesis was performed using Polymerase I and RNaseH with replacement of dTTP for dUTP. The generated cDNA fragments were 3′ end adenylated and ligated to Illumina Paired-end sequencing adapters and subsequently amplified by 12 cycles of PCR. The libraries were analyzed on a 2100 Bioanalyzer using a 7500 chip (Agilent, Santa Clara, CA), diluted and pooled equimolar into a 10nM multiplex sequencing pool.

#### Sequencing {#sec4.4.20.3}

The libraries were sequenced with 65 base single reads on a HiSeq2500 using V4 chemistry (Illumina).

### Quantification and Statistical Analysis {#sec4.4.21}

While mentioned, n represents the number of biological repeats of the same experiment. Data are represented as mean ± SEM. p values presented in [Figures 3](#fig3){ref-type="fig"}A,E; 4A,D; S5B,C; S6A,B were calculated using Wilcoxon's test. p values mentioned in other figures were calculated using t test (one-tail distribution, homoscedastic variance). In all figures, ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.005, ^∗∗∗∗^p \< 0.001.

### Polysomal Data Analysis and Preparation of Heatmaps {#sec4.4.22}

Polysomal fractions and promoter vectors were identified by their unique indexes and barcodes, respectively. Expression count matrix was derived by counting the frequency of each barcode in each fraction. To avoid fluctuations due to low coverage, only vectors covered by at least 10,000 counts (summation over all fractions) were included in the analyses. For heatmap display, vector counts (rows) were standardized to mean = 0 and SD = 1. Heatmaps were generated using the EXPANDER package ([@bib36]). Order of promoter vectors in the heatmap was determined by hierarchical clustering of the rows.

### RNA-Seq and Ribo-Seq Analysis {#sec4.4.23}

Sequenced reads were aligned to a reference set of human curated protein-coding transcripts (plus the five human rRNA transcripts) using Bowtie ([@bib16]). This reference set of transcripts was based on Ensembl's gene annotations (release 69). For genes with multiple isoforms, the one with longest coding DNA sequence (CDS) region and, in case not unique, the one with longest UTRs among the ones with the longest CDS, was selected to represent the gene. Only uniquely mapped reads were used in subsequent analyses. RNA expression levels and ribosome occupancy were estimated by calculating reads per kilobase of mRNA per million reads (RPKM) per transcript, taking into account either all reads that map to the transcript (for estimation of RNA levels using RNA-seq data) or only those mapping to its CDS (for estimation of ribosome occupancy). In estimation of ribosome occupancy in CDS, 5′ ends of reads were offset 12 nucleotides to the 3′ direction to match the P-site location of ribosome ([@bib13]). Translation efficiency (TE) was estimated by the (log~2~) ratio between ribosome occupancy and mRNA level. Only genes with at least 20 reads in RNA-seq and Ribo-seq samples were included in analyses.

### GRO-Seq Analysis {#sec4.4.24}

Sequenced reads were aligned to the human genome (hg19) using bowtie2, and number of reads mapping to annotated genes (Ensembl v69) were counted by HTseq ([@bib1]). Quantile normalization was then applied to allow comparisons between different samples. Only genes covered by at least 20 reads were included in the analysis.

Data and Software Availability {#sec4.5}
------------------------------

The deep sequencing datasets generated in this study have been deposited in the GEO database under accession number GEO: [GSE96643](ncbi-geo:GSE96643){#intref0060}.
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![A Screen for Examination of the Relationship between Transcription and Translation\
(A) Schematics of the barcoded polysomal profiling (BPP) approach.\
(B) A typical segregation of *Rluc* mRNAs.\
(C) Control *Rluc* transcript with 5′ TOP sequence exhibits rapid shift to non-translating fractions upon inhibition of mTORC1.\
(D) Control *Rluc* transcript shifts to denser fractions following splicing. The bar diagram below represents normalized relative Rluc protein expression assessed by luciferase assay in two separate clones.\
See also [Figure S1](#figs1){ref-type="fig"}.](gr1){#fig1}

![Presence of the TATA Element in Promoters Enhances TE\
(A) Pro-Lib vectors encoding for TATA-containing promoters result in *Rluc* mRNAs shifted to the denser fractions of the gradient compared to other transcripts (e.g., under SPTBN1 promoter).\
(B) Pro-Lib vectors supplied with an artificial TATA yield *Rluc* mRNAs that are shifted to the denser fractions of the gradient compared to the parental TATA-less promoters.\
(C) Northern blot analysis of *Rluc* mRNAs; quantification reflects relative *Rluc*/*Fluc* ratio.\
(D) Relative levels of Rluc mRNAs and proteins produced by promoters with or without TATA element; note the super-induction of the protein expression. Data are represented as mean ± SEM, n = 4.\
(E) Relative levels of Rluc mRNAs and proteins produced by SV40 promoter upon mutagenesis of TATA; data are represented as mean ± SEM, n = 3.\
(F) Mutagenesis of SV40 promoter-derived TATA results in less efficient translation of *Rluc* mRNA as detected by BPP; data are represented as mean ± SEM of a representative gradient, n = 2.\
(G) Schematics of the CRISPR-Cas9-mediated mutagenesis of the endogenous TATA (in pink square) of *c-Myc*. Below: characterization of the different *c-Myc* alleles of one of the isolated clones, including relative abundances.\
(H) Mutagenesis of the c-Myc TATA results in lowered mRNA levels (left chart) and further reduced c-Myc activity (right chart); data are represented as mean ± SEM of n = 3.\
(I) Western blot analysis of c-Myc protein in the TATA-mutated clone and WT MCF7 cells; see [Figure S2](#figs2){ref-type="fig"}I for the uncropped blot.\
(J) Polysomal profilings of *c-Myc* mRNAs isolated from the clone with mutated TATA and WT MCF7 cells; data are represented as mean ± SEM of a characteristic gradient; n = 3.\
See also [Figures S2](#figs2){ref-type="fig"}G--S2K for the characterization of an additional clone.](gr2){#fig2}

![Levels of mRNAs Positively Correlate with TE but Do Not Dictate It\
(A) Reporter mRNAs from the Pro-Lib screen were separated into groups with relatively high or low TE (derived from the polysomal profiles, see [Figure S4](#figs4){ref-type="fig"}) and compared with their expression levels (estimated from read counts observed for each vector over all fractions). p values calculated using Wilcoxon's test.\
(B) Same comparison as described in (A) was performed after exclusion of mRNAs transcribed from promoters with artificial TATA element.\
(C) Levels of mRNA and protein resulting from the induced TRex-Rluc gene were measured and plotted relatively to the non-induced condition; data are represented as mean ± SEM of n = 3.\
(D) BPP examination of either induced or non-induced *TRex-Rluc* mRNAs; data are represented as mean ± SEM of a characteristic gradient; n \> 5, see also [Figure S5](#figs5){ref-type="fig"}A.\
(E) Upper panels: paired RNA-seq and Ribo-seq datasets from different human cell lines were examined for relationship between mRNA expression level and TE (calculated as the (log~2~) ratio between densities of ribosome footprint and RNA-seq reads). Lower panels: comparisons between the 10% of genes with lowest and highest expression levels are presented; p values calculated using Wilcoxon's test.\
(F) MCF7 cells were transfected with fold-wise amounts of in vitro transcribed (using HeLa nuclear extract) *Rluc* mRNA followed by measurement of RLuc activity after 18 hr; data are represented as mean ± SEM of n = 3.\
(G) Levels of Rluc mRNA and protein were compared between two populations of MCF7 cells expressing near single or multiple integrated copies of Lenti-Rluc unit. Data are represented as mean ± SEM of n = 3.\
(H) BPP analysis of *Rluc* transcripts described in (G); data are represented as mean ± SEM of a characteristic gradient, n = 3.](gr3){#fig3}

![TE is Affected by the Rate of Transcription\
(A) Upper panels: positive genome-wide correlations between translational efficacies and rates of transcription in BJ and MCF7 cells. Lower panels: direct comparisons between 10% of genes with lowest and highest transcription rates. GRO-seq data were from ([@bib15], [@bib17]); Ribo-seq and RNA-seq data were from ([@bib18]); p values were calculated using Wilcoxon's test.\
(B) Expression levels of Rluc mRNA and protein were examined following parallel induction of the TRex-Rluc gene and CPT treatment for 7 hr; data are represented as mean ± SEM of n = 3.\
(C) Lysates of the two populations described in (B) were subjected to BPP procedure; data are represented as mean ± SEM of a characteristic gradient, see also [Figure S5](#figs5){ref-type="fig"}D; n = 3.\
(D) Upper panels: genome-wide correlations between rates of transcription and TE changes after treatment with CPT. Lower panels: direct comparison of the effect on TE between the 10% of most highly and lowly transcribed genes; p values were calculated using Wilcoxon's test.\
(E) Polysomal profilings of mRNAs after CPT treatment (red) show reduced TE compared to untreated cells (green). Columns represent the relative mRNA levels as detected by qRT-PCR; *ALG8* was used as a control gene. Data are presented as mean ± SEM of three technical measurements of a characteristic graident; n = 3. See also [Figure S6](#figs6){ref-type="fig"}C.\
(F) Cells with barcoded TRex-IRES-Rluc cassette (schematics) were induced for 18 hr and subjected for examination of *Rluc* mRNA and protein levels relative to the non-induced cells; data are presented as mean ± SEM of n = 3.\
(G) Same cells as in (F) were treated in a similar way and subjected to BPP procedure. Data are presented as mean ± SEM of three measurements of a characteristic gradient; n = 3.\
(H) Pro-Lib vectors with SZT2 promoters, with or without the TATA element, were supplemented with IRES-encoding sequence as shown on the schematics. Cells expressing these constructs were subjected to quantification of mRNA and protein levels; data are presented as mean ± SEM of n = 3.](gr4){#fig4}

![Enhancement of m^6^A Modification of mRNAs upon Attenuated Transcription\
(A) Cells bearing the TRex-Rluc gene were induced for 18 hr and subjected to the MeRIP procedure, together with untreated cells. Recovery efficiencies of regions spanning the *Rluc* mRNA were examined, normalized to the input levels and compared; *AHNAK* was used as a control methylated mRNA. Data are represented as mean ± SEM of n = 3.\
(B) *Rluc* mRNAs were transcribed in vitro using HeLa extract as detailed, resolved on agarose gels and quantified (left chart, n = 3) and further subjected to the relative comparison of their m^6^A contents (right chart, n = 2).\
(C) Total RNA isolated from MCF7 cells treated with CPT for 5 hr was enriched for polyA^+^ population and quantified (left chart, n = 3) and further subjected to the relative comparison of their m^6^A contents (right chart, n = 3).\
(D) mRNAs presented in [Figure 4](#fig4){ref-type="fig"}E were tested for recovery after MeRIP procedure (striped columns) relatively to their RNA levels (plain columns) using qRT-PCR. Data are represented as mean ± SEM of n = 2. See also [Figures S6](#figs6){ref-type="fig"}D and S6E.\
(E) Relative levels of polyA+ RNA populations (plain columns) in cells expressing different RNAPII mutants, and their relative m^6^A levels (striped columns) were examined; n = 2.\
(F) MCF7 cells were treated with CPT for 5 hr and subjected to immuno-precipitation of RNAPII, followed by detection of METTL3 protein using western blot. A characteristic blot is presented, n = 4. In the input panel, GAPDH was probed on a separate blot.](gr5){#fig5}

![Effect of the m^6^A Modifications on Translation\
(A) *Rluc* mRNAs were transcribed in vitro using HeLa extract in the indicated conditions, and transfected into MCF7 cells in fold-wise amounts; RLuc enzymatic activity was measured after 24 hr. The trend lines are represented by the dashed lines; n = 3.\
(B) MCF7 cells were treated with CPT for 5 hr and subjected to polysomal profiling with subsequent measurement of the average levels of total RNA in the collected fractions. Data are presented as mean ± SEM, n = 3.\
(C) Polysomal segregation of total RNA from cells expressing "normal speed" or "slow" RNAPII; data are presented as mean ± SEM of n = 3. See also [Figure S6](#figs6){ref-type="fig"}H.\
(D) TRex-Rluc gene was induced for 18 hr in MCF7 cells transfected with the detailed siRNAs, or left uninduced. Expression levels of RLuc protein were assessed; data are represented as mean ± SEM of n = 3.\
(E) Cells bearing the TRex-Rluc gene were transfected with the indicated siRNAs, grown for 56 hr and subjected to BPP. Upper panel: non-induced Rluc; lower panel: Rluc expression was induced for 24 hr prior to harvesting; data are represented as mean ± SEM of three measurements of a characteristic gradient; n = 3.\
(F) Results of the MeRIP experiment presented in [Figure 5](#fig5){ref-type="fig"}A were normalized to calculate the total relative recovery of *Rluc* mRNAs by the different regions. Error bars represent mean ± SEM of n = 3.\
(G) *Rluc* mRNAs were in vitro transcribed using T7 polymerase in the presence of the indicated proportions of m^6^A nucleoside and in vitro translated using indicated amounts of mRNA as input. Data are represented as mean ± SEM of n = 4.\
(H) Model of the transcription-dependent regulation of TE. Slow or paused RNAPII results in the enhanced interaction with MTC (step 1), which leads to enhanced deposition of m^6^A on mRNAs (step 2), negatively affecting translation efficiency (step 3).](gr6){#fig6}

![Setup of the Promoter Library (Pro-Lib) and Barcoded Polysomal Profiling (BPP), Related to [Figure 1](#fig1){ref-type="fig"}\
(A) Schematics of the Pro-Lib vector. The reporter Rluc gene is flanked upstream by sequences encoding for putative promoters of interest (magenta colored) and downstream by unique 10-nt barcodes (also magenta colored). Transcription of the control Fluc gene is driven by HSV-TK promoter in all vectors.\
(B) Several Pro-Lib vectors with the indicated regions cloned upstream of Rluc gene were integrated into MCF7/FRT cells, grown separately and subjected to dual Rluc/Fluc assay. Note the uniform expression of the tested constructs that is substantially higher than the background signal (assessed by expression of vectors with no promoter or with random intron sequence cloned instead of a promoter) and milder than the expression of the strong SV40 promoter. Data are represented as mean ± SEM of n = 3.\
(C) Total RNA isolated from fractions of a typical BPP experiment were separated on 1.5% agarose gels and documented. Note the characteristic segregation of RNA as well as the relative enrichment of ribosomal RNAs in the polysomal fractions.\
(D) Total RNA concentrations in the different fractions were measured following lysis of cells in the presence or absence of EDTA and polysomal profiling procedure. Note the dramatic drop of the RNA content in the fractions 9-13 upon presence of EDTA in the lysis buffer.\
(E) BPP experiment identifies two *Rluc* transcripts (driven by SV40 and CD44 promoters) exhibiting super-sensitivity to the inhibition of mTORC1. Note the multiple barcodes for each promoter showing identical behavior.\
(F) The transcripts mentioned in (E) contain putative 5′TOP sequences (marked in blue). The TSS of the SV40 promoter was reported previously ([@bib2]), while the TSS of the CD44-driven construct was determined by 5′-RACE analysis in this study.](figs1){#figs1}

![Effect of TATA Box on TE, Related to [Figure 2](#fig2){ref-type="fig"}\
(A) Pro-Lib vectors encoding for promoters with TA-rich regions at their 3′ ends result in Rluc mRNAs shifted to the denser fractions of the gradient, compared to other transcripts (e.g., under SPTBN1 promoter).\
(B) Average standardized profiles of polysome fractions for the TATA+/TATA- paired constructs in Pro-Lib.\
(C) Promoter region of ASNSD1 gene yields better translated Rluc mRNAs when supplemented with an artificial TATA box at its 3′end. Cells expressing *Rluc* mRNAs from either native ASNSD1 promoter or with artificial TATA box were subjected to BPP and plotted for a direct comparison of TE (left panel). To test the robustness of the positive effect of TATA on TE, cells were subjected to various stress conditions, prior to BPP (right panels). Note that in all listed conditions the presence of TATA box enhances TE.\
(D) Point mutagenesis of the artificial TATA box reduces mRNA levels and prevents super-induction of the protein production. SZT2 and ASNSD1 promoters supplemented with an artificial TATA box were subjected to site-directed mutagenesis of the TATA box sequence (muTATA). Levels of the Rluc mRNAs and protein compared to the native promoters (lacking TATA) are shown; data are represented as mean ± SEM of n = 3.\
(E) *Rluc* mRNAs resulting from either native ASNSD1 promoter, one with the artificial TATA box (+TATA) or with a point-mutated TATA sequence (muTATA) were subjected to the BPP procedure. Note the shift toward denser fractions caused by the artificial addition of TATA box as well as the shift to the opposite direction upon mutation of the TATA sequence.\
(F) Screenshot of the DBTSS database (release 9.0) showing the distribution of TSS of c-Myc gene in MCF7 cells. Note that most of TSSs stem from a single TATA box-containing promoter (see zoom-in window).\
(G) Genotyping of the c-Myc proximal promoter region of the second clone bearing modified c-Myc TATA box. Numbers on the left represent relative abundances of the different alleles.\
(H) Lysates of the clone described in (G) were subjected to polysomal profiling and plotted against wild-type MCF7 cells. SEM represents three measurements of a characteristic gradient; n = 2. ^∗∗∗^p \< 0.005, ^∗∗∗∗^p \< 0.001.\
(I) Lysates of the two clones bearing modified c-Myc TATA boxes together with wild-type MCF7 cells (WT TATA) and cells transfected with vector encoding for c-Myc (Myc OE), were resolved on SDS-PAGE and probed for c-Myc and GAPDH proteins. Replicates on the blot represent biological repeats.\
(J) Relative quantification of the c-Myc bands presented in (I).\
(K) TE of a control gene (ALG8) was assessed by probing polysomal fractions described in [Figure 2](#fig2){ref-type="fig"}J with primers detecting ALG8 mRNA. SEM represents three measurements of a characteristic gradient; n = 3.](figs2){#figs2}

![Analysis of *Rluc* mRNAs, Related to [Figures 2](#fig2){ref-type="fig"}, [3](#fig3){ref-type="fig"}, [5](#fig5){ref-type="fig"}, and [6](#fig6){ref-type="fig"}\
(A and B) *Rluc* mRNAs transcribed by ASNSD1 (A) or SZT2 (B) promoters either lacking or bearing an artificial TATA box were subjected to 5′RACE analysis in order to determine their TSSs. Reads were plotted in a quantitative manner using IGV software. Note the first ATG of the Rluc ORF and the precise focusing of the TSS by the TATA box.\
(C) Evaluation of the effect of the different 5′UTRs on TE. Rluc transcripts bearing the different 5′UTRs identified in A,B (see the numbered arrows) were transcribed in vitro using T7 RNA polymerase, polyadenylated and transfected into MCF7 cells in fold-wise amounts. Renilla luciferase activity was measured 24 hr later and plotted in a relative manner to draw the trend lines that represent the respective ratios of translation. The rightmost panel shows the absolute Rluc signals; n = 4.\
(D) *Rluc* mRNAs expressed from either induced or non-induced *TRex-Rluc* gene were subjected to 5′RACE analysis. Reads (numbers of sequenced colonies) were plotted in a quantitative manner on a scale ranging from TATA box (−243) to ATG (+1).\
(E) *Rluc* transcripts produced in vitro using HeLa extract in optimal conditions (1.5mM Mg++), upon high MgCl~2~ (3mM Mg++) or from promoter with mutated TATA element (muTATA) were subjected to 5′- and 3′-RACE analyses. The reads from both assays were analyzed and plotted in a quantitative manner using IGV software.\
(F) Transcripts described in (E) were subjected to analysis of the length of polyA-tails.\
(G) The *TRex-Rluc* cassette was induced for 24 hr in cells transfected with the indicated siRNAs. After isolation of total RNA, the 5′- and 3′ ends of the Rluc mRNAs were determined as detailed in (E).](figs3){#figs3}

![Global TE Assessment of the Pro-Lib mRNAs, Related to [Figure 3](#fig3){ref-type="fig"}\
Barcoded *Rluc* mRNAs with sufficient read coverages (\> 10.000 reads over 15 polysomal fractions) in three independent BPP experiments were divided into two main groups by hierarchical clustering. One arm includes barcodes that showed peak in fractions 9-11 (lower TE, A-B) and the other arm includes barcodes whose polysomal profile peaked in fraction 11-13 (higher TE, C-D). Plots to the right of the heatmaps show the mean profile of the vectors assigned to each group over the three repeats; error bars = SD.](figs4){#figs4}

![Transcription rates impacts translation, Related to [Figures 3](#fig3){ref-type="fig"} and [4](#fig4){ref-type="fig"}\
(A) Segregation of the induced versus non-induced *Rluc* mRNAs on sucrose gradients. Cells expressing barcoded *Rluc* gene were treated for 21 hr to induce the expression of *Rluc* or left untreated, and subjected to BPP procedure.\
(B) Upper panels: test for correlation between mRNA expression and TE, as described in [Figure 3](#fig3){ref-type="fig"}E, was performed here on data from BJ cells in quiescent, senescent, and transformed states. Lower panels: direct comparison between 10% of mRNAs with the lowest and 10% with the highest abundance.\
(C) In MCF7 cells, a similar correlation was tested in p53-activated (by Nutlin3 treatment) versus the control cells. Both datasets are from ([@bib18]), representation as detailed for (B).\
(D) Cells with induced Rluc were treated with CPT (or DMSO) for 5 hr and subjected to BPP analysis.](figs5){#figs5}

![Related to [Figures 4](#fig4){ref-type="fig"} and [5](#fig5){ref-type="fig"} and [6](#fig6){ref-type="fig"}\
(A) Genes with high ribosomal occupancy in their 5′UTRs show overall reduced TE in both BJ and MCF7 cells; p values were calculated Wilcoxon's test.\
(B) These genes do not display any clear correlation between their transcription rate and TE (showing two independent replicates), and were removed from the genome-wide analysis.\
(C) Treatment with CPT causes attenuation of translation. Transcripts showed in [Figure 4](#fig4){ref-type="fig"}E and additional mRNAs were detected in polysomal profiling experiments using primers against their 3′ UTRs.\
(D) *Rluc* mRNAs produced in cells stably expressing Lenti-Rluc cassette integrated at either single- or multiple-copy numbers, were subjected to MeRIP procedure and analyzed by qRT-PCR. In each experiment, the level of recovery from cells with multi-copy integration was calculated relatively to the recovery of the single-copy population; n = 4.\
(E) *Rluc* mRNAs transcribed from the promoter pairs with or without intact TATA box element were subjected to MeRIP procedure and analyzed by qRT-PCR; n = 2.\
(F) Efficiency of METLL14 and YTHDF1 siRNA-mediated knockdown. MCF7 cells were transfected with siRNAs targeting METTL14 or YTHDF1 genes or control non-targeting siRNA. After 56 hr, the cells were harvested, subjected to RNA isolation and tested for the levels of the respective mRNAs using qRT-PCR.\
(G) MCF7 cells transfected with the indicated siRNAs were subjected to polysomal profiling procedure and an average levels of RNA in the collected fractions were measured using NanoDrop and plotted; n = 2.\
(H) Cells expressing "normal speed" or "slow" mutants of RNAPII were subjected to polysomal profiling on sucrose gradients. Several mRNAs were detected using qRT-PCR to monitor changes in their TE; a characteristic profile is shown, n = 2.](figs6){#figs6}
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